Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by St. Jude Children's Research Hospital
Sponsor:
Collaborators:
Genzyme, a Sanofi Company
National Cancer Institute (NCI)
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00703820
First received: June 20, 2008
Last updated: November 2, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2019
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)